Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient.

Clinicians often are faced with an increase in liver enzyme levels. In the majority of cases, the cause is found rapidly. Conversely, in a few cases, the etiologic agent remains unknown and requires either liver biopsy or drug-medication modification. We report a case of acute icteric hepatitis associated with renal function impairment related to infection caused by primary hepatitis E virus (HEV) in a renal transplant recipient who lived in a nonclassic endemic area and had not traveled abroad. Clinicians must be aware that in cases of unexplained hepatitis in organ transplant recipients and in the absence of evident drug hepatotoxicity, HEV should be considered as an etiologic agent for hepatitis. Subsequently, HEV serological tests should be performed, HEV RNA should be looked for in acute-phase serum and stool samples, and liver parameters should be monitored closely because HEV might be responsible, in some cases, for fulminant hepatitis.

[1]  N. S. Murthy,et al.  Hepatitis E in pregnancy , 2004 .

[2]  R. Girones,et al.  Evidence for the presence of hepatitis E virus in pigs in the United Kingdom , 2004, Veterinary Record.

[3]  J. Izopet,et al.  Immunologically Silent Autochthonous Acute Hepatitis E Virus Infection in France , 2004, Journal of Clinical Microbiology.

[4]  T. Toyota,et al.  Three male patients with sporadic acute hepatitis E in Sendai, Japan, who were domestically infected with hepatitis E virus of genotype III or IV , 2004, Journal of Gastroenterology.

[5]  S. Emerson,et al.  Hepatitis E virus , 2003, Reviews in medical virology.

[6]  S. Mishiro,et al.  A case report: two patients with fulminant hepatitis E in Hokkaido, Japan. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[7]  S. Lakhtakia,et al.  Acute pancreatitis following kidney transplantation – role of viral infections , 2003, Clinical transplantation.

[8]  J. Izopet,et al.  1067 Acute hepatitis E: a study of 17 consecutive patients in South-West France over a 13 month period , 2003 .

[9]  M. Grandadam,et al.  Viraemia and faecal shedding of HEV in symptom-free carriers , 2001, The Lancet.

[10]  A. W. Tam,et al.  Diagnostic Value of Immunoglobulin G (IgG) and IgM Anti-Hepatitis E Virus (HEV) Tests Based on HEV RNA in an Area Where Hepatitis E Is Not Endemic , 2000, Journal of Clinical Microbiology.

[11]  J. Iredale,et al.  Sporadic acute hepatitis E in the United Kingdom: an underdiagnosed phenomenon? , 2000, Gut.

[12]  R. Calne,et al.  Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. , 1999, Transplantation.

[13]  L. Ardiles,et al.  Anti-HEV in dialysis and renal transplant patients in an endemic region in Chile. , 1998, Clinical nephrology.

[14]  M. Elisaf,et al.  Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit , 1998, Transfusion.

[15]  J. Rosenblatt,et al.  Acute hepatitis E by a new isolate acquired in the United States. , 1997, Mayo Clinic proceedings.

[16]  D. Vlahov,et al.  Seroreactivity to hepatitis E virus in areas where the disease is not endemic , 1997, Journal of clinical microbiology.

[17]  F. Carnot,et al.  Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis. , 1996, Transplantation.

[18]  A. Hatzakis,et al.  Hepatitis E virus (HEV) infection in haemodialysis patients , 1996 .

[19]  P. Laurent-Puig,et al.  A high hepatitis E virus seroprevalence among renal transplantation and haemophilia patient populations. , 1996, Journal of hepatology.

[20]  B. Portmann,et al.  Detection of hepatitis E virus genome and gene products in two patients with fulminant hepatitis E. , 1995, Journal of hepatology.

[21]  J. Donoghue,et al.  Hepatitis E virus antibody prevalence , 1994, The Lancet.

[22]  D. Ouzan,et al.  High prevalence of hepatitis E virus antibody in haemodialysis patients , 1994, The Lancet.